Operational strategies of anti-malarial drug campaigns for malaria elimination in Zambia’s southern province: a simulation study

Table 2 Experiment design for campaign implementation with dihydroartemisinin–piperaquine (DHAP)

Drug combination	Population reached by MTAT campaign	Population reached by MDA campaign	Ivermectin duration of effectiveness	Single low-dose (SLD) primaquine half-life
Campaign implementation with DHAP	40, 72 %	40, 72 %
DHAP + ivermectin	40, 72 %^a	40, 72 %	2, 4, 7 days
DHAP + SLD primaquine		40, 72 %		12, 48, 72 h
DHAP + ivermectin + SLD primaquine		40, 72 %

Baseline values indicated in italics
^aIn this scenario ivermectin is given to every individual reached by the campaign, regardless of the result of their malaria test

ISSN: 1475-2875